Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-06-14
2005-06-14
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
Reexamination Certificate
active
06905846
ABSTRACT:
Nucleic acids encoding factor XΔ analogues having a deletion of amino acids Arg180 to Arg234 and a modification in the region of the amino acid sequence between Gly173 and Arg 179 are provided.
REFERENCES:
patent: 4359049 (1982-11-01), Redl et al.
patent: 4501731 (1985-02-01), Tishkoff et al.
patent: 4735616 (1988-04-01), Eibl et al.
patent: 5460950 (1995-10-01), Barr et al.
patent: 5597799 (1997-01-01), Wolf
patent: 5635481 (1997-06-01), Wolf
patent: 5858658 (1999-01-01), Haemmerle et al.
patent: 6210929 (2001-04-01), Schlokat et al.
patent: 6562598 (2003-05-01), Himmelspach et al.
patent: 6573071 (2003-06-01), Himmelspach et al.
patent: 0 651 054 (1995-03-01), None
patent: WO 94/29370 (1994-12-01), None
Himmelspach, M. et al. “Alteration of the Specificity of fX Activation by Substitution of Amino Acids Constituting its Activation Site”,XVII Congress of the International Society on Thrombosis and Haemostasis, 1999, p. 758.
Bajaj, S. & Mann, K. “Simultaneous Purification of Bovine Prothrombin and Factor X.”J. Biol. Chem., Nov. 25, 1973, pp. 7729-7741, vol. 248, No. 22.
Barr, P.J. “Mammalian Subtilisins: The Long-Sought Dibasic Processing Endoproteases.”Cell, 1991, pp. 1-3, vol. 66.
Clackson, T. et al.PCR A Practical Approach; General Applications of PCR to Gene Cloning and Manipulation, Eds. McPherson, Quirke and Taylor, 1991, pp. 187-214.
Eby. C.S. et al. “Characterizastion of the Structure and Function of the Carboxy Terminal Peptide of Human Factor X.”Blood, 1992, pp. 1214, vol. 80, Suppl. 1.
Elsinger, R.Laboratory Tests of Activated Prothrombin Complex Preparations: Activated Prothrombin Complex Concentrates, 1982, pp. 77-87, Chapter 11, Eds. Mariani, Russo and Mandelli, Praeger Publishers, U.S.A.
Fair, D.S. and Bahnak, B.R. “Human Hepatoma Cells Secrete Single Chain Factor S. Prothrombin, and Antithrombin III.”Blood, Jul. 1984, pp. 194-204, vol. 64, No. 1.
Fischer et al. “Structural Analysis of Recombinant von Willebrand Factor: Identification of hetero-and homo-dimers”,FEBS Lett., 1994, pp. 345-348, vol. 351.
Fung, M. et al. “Characterization of an almost full-length cDNA coding for human blood coagulation factor X ”Proc. Natl. Acad. Sci. USA, Jun. 1985, pp. 3591-3595, vol. 82.
Giles, A. et al. “A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo.”British J. Haemotology, 1988, pp. 491-497, vol. 69.
Gordon, V.M. et al. “Proteolytic Activation of Bacterial Toxins by Eukaryotic Cells is Performed by Furin and by Additional Cellular Proteases.”Infec. Immunol., 1995, pp. 82-87, vol. 63.
Jesty, J. et al. “The Mechanism of Activation of Factor X: Kinetic Control of Alternative Pathways Leading to the Formation of Activated Factor X”J. Biol. Chem., Sep. 10, 1974, pp. 5614-5622, vol. 249, No. 17.
Leytus, S. et al. “Characterization of cDNA coding for human factor X.”Proc. Natl. Acad. Sci. USA, Jun. 1984, pp. 3699-3702, vol. 81.
Leytus, S. et al. “Gene for Human Factor X: A Blood Coagulation Factor Whose Gene Organization is Essentially Identical with that of Factor IX and Protein C.”Biochem., 1986, pp. 5098-5102, vol. 25.
Mertens, K. & Bertina, R. “Pathways in the Activation of Human Coagulation Factor X”Biochem. J., 1980, pp. 647-658, vol. 185.
Messier, T. et al. “Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation factor X.”Gene, 1991, pp. 291-294, vol. 99, Elsevier.
Moehring, J.M. & Meohring, T.J. “Strains of CHO-K1 Cells Resistant to Peudomonas Exotoxin A and Cross-Resistant to Diphtheria Toxin and Viruses.”Infection and Immunity, 1983, pp. 998-1009, vol. 41.
Morita et al. “Structural and Functional Characteristics of a Proteolytically Modified ‘Gla Domain-less’ Bovine Factor X and Xa (des light chain residues 1-44).”General Biochem., 1980, p. 219, vol. 92, abstract No. 92:71374k.
Ngo et al.Computational Complexity, Protein Structure Prediction and the Levinthal Paradox in the Protein Folding Problem and Tertiary Structure, 1994, Eds. K. Mez, Jr. and Le Grand, Birkhauser, Boston.
Ohnishi, Y. et al. “A Furin-Defective Cell Line is Able to Process Correctly the gp160 of Human Immunodeficiency Virus Type 1.”J. Virol., 1994, pp. 4075-4079, vol. 68.
Pryzdial, E. & Kessler, G. “Autoproteolysis or Plasmin-mediated Cleavage of Factor Xaα Exposes a Plasminogen Binding Site and Inhibits Coagulation.”J. Biol. Chem., Jul. 12, 1996, pp. 16614-16620, vol. 271, No. 28.
Pryzdial, E. & Kessler, G. “Kinetics of Blood Coagulation oFactor Xaα Autoproteolytic Conversion of Factor Xaβ.”J. Biol. Chem., Jul. 12, 1996, pp. 16621-16626, vol. 271, No. 28.
Rehemtulla, A. & Kaufman, R.J. “Preferred Sequence Requirements for Cleavage of Pro-von Willebrand Factor by Propeptide-Processing Enzymes.”Blood, 1992, pp. 2349-2355, vol. 79.
Rudolph, A.E. et al. “Expression, Purification and Characterization of Recombinant Human Factor X1.”Protein Expression and Purification, 1997, pp. 373-378, vol. 10.
Sherrill, G.B. et al. “Inactivation of Human Blood Coagulation Factor X by Chemical Modification of Gamma-Carboxyglutamic Acid Residues.”Enzymes, 1985, p. 239, vol. 102, Abstract No. 102:2489q.
Teng, C. & Seegers, W. “Production of factor X and Xa variants with thrombin, acutin and by autolysis.”Thrombosis Research, 1981, pp. 213-220, vol. 22.
Urlaub, G. & Chasin, L. “Isolation of Chinese hamster cell mutants deficient on dihydrofolate reductase activity.”Proc. Natl. Acad. Sci. USA, Jul. 1980, pp. 4216-4220, vol. 77, No. 7.
Wallin, R. et al. “Intracellular Proteolytic Processing of the Two-Chain Vitamin K-Dependent Coagulation Factor X.”Thrombosis Res., 1994, pp. 395-403, vol. 73.
Watzke, H. & High, K. “Factor X.”Molecular Basis of Thrombosis and Haemostasis, 1995, pp. 239-255, Chapter 11, Eds. High and Roberts.
Wells et al. “Additivity of Mutational Effects In Proteins.”Biochemistry, 1990, pp. 8509-8517, vol. 29, No. 37.
Wolf, D. et al. “Design of Constructs for the Expression of Biologically Active Recombinant Human Factors X and Xa.”J. Biol. Chem., Jul. 25, 1991, pp. 13726-13730, vol. 266, No. 21.
Dorner Friedrich
Eibl Johann
Falkner Falko-Guenter
Himmelspach Michele
Pfleiderer Michael
Baxter Aktiengesellschaft
Carlson Karen Cochrane
Snedden Sheridan K
Townsend and Townsend / and Crew LLP
LandOfFree
Nucleic acids encoding factor X deletion mutants and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids encoding factor X deletion mutants and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding factor X deletion mutants and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464089